- Home
- GTIM vs TPST Comparison
GTIM vs TPST Comparison
Compare GTIM & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTIM | TPST |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 11.1M |
| IPO Year | 2013 | 2012 |
Fundamental Metrics
Financial Performance| Metric | GTIM | TPST |
|---|---|---|
| Price | $1.21 | $2.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 29.4K | ★ 53.5K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 21.47 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $142,315,000.00 | $295,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $59.50 | ★ N/A |
| Revenue Growth | ★ 3.01 | N/A |
| 52 Week Low | $1.10 | $0.60 |
| 52 Week High | $2.65 | $12.22 |
Technical Indicators
Market Signals| Indicator | GTIM | TPST |
|---|---|---|
| Relative Strength Index (RSI) | 45.77 | 42.71 |
| Support Level | $1.16 | $2.14 |
| Resistance Level | $1.25 | $2.52 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 21.46 | 49.37 |
Price Performance
Historical ComparisonAbout GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.